Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt
Related Experiment Video
Updated: Jun 28, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Kazuyuki Yamagata1, Hiroaki Daitoku, Yuta Takahashi
1Center for Tsukuba Advanced Research Alliance, Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba 305-8577, Japan.
Abstract:
Forkhead box O (FOXO) transcription factors, the key regulators of cell survival, are negatively controlled through the PI3K-Akt signaling pathway. Phosphorylation of FOXO by Akt leads to cytoplasmic localization and subsequent degradation via the ubiquitin-proteasome system. Here we show a paradigm of FOXO1 regulation by the protein arginine methyltransferase PRMT1. PRMT1 methylated FOXO1 at conserved Arg248 and Arg250 within a consensus motif for Akt phosphorylation; this methylation directly blocked Akt-mediated phosphorylation of FOXO1 at Ser253 in vitro and in vivo. Silencing of PRMT1 by small interfering RNA enhanced nuclear exclusion, polyubiquitination, and proteasomal degradation of FOXO1. PRMT1 knockdown led to a decrease in oxidative-stress-induced apoptosis depending on the PI3K-Akt signaling pathway. Furthermore, stable expression of enzymatic inactive PRMT1 mutant increased resistance to apoptosis, whereas this effect was reversed by expression of phosphorylation-deficient FOXO1. Our findings predict a role for arginine methylation as an inhibitory modification against Akt-mediated phosphorylation.
Insights
Protein arginine methyltransferase 1 (PRMT1) regulates Forkhead box O1 (FOXO1) stability by blocking Akt phosphorylation. This methylation prevents FOXO1 degradation, impacting cell survival and apoptosis.
Area of Science:
- Molecular Biology
- Cell Signaling
- Epigenetics
Background:
- Forkhead box O (FOXO) transcription factors are crucial for cell survival.
- FOXO activity is negatively regulated by the PI3K-Akt signaling pathway.
- Akt-mediated phosphorylation targets FOXO for cytoplasmic localization and proteasomal degradation.
Purpose of the Study:
- To investigate the role of protein arginine methyltransferase 1 (PRMT1) in FOXO1 regulation.
- To elucidate the mechanism by which PRMT1 affects FOXO1 stability and function.
- To determine the impact of PRMT1-mediated FOXO1 modification on apoptosis.
Main Methods:
- In vitro and in vivo methylation assays using PRMT1 and FOXO1.
- Small interfering RNA (siRNA) to silence PRMT1 expression.
- Analysis of FOXO1 localization, ubiquitination, and degradation.
- Assessment of apoptosis under oxidative stress conditions.
- Expression of wild-type and mutant PRMT1 and FOXO1.
Main Results:
- PRMT1 methylates FOXO1 at Arg248 and Arg250, inhibiting Akt phosphorylation at Ser253.
- PRMT1 silencing enhances FOXO1 nuclear exclusion, polyubiquitination, and proteasomal degradation.
- PRMT1 knockdown reduces oxidative-stress-induced apoptosis.
- Expression of inactive PRMT1 mutant increases apoptosis resistance, reversed by phosphorylation-deficient FOXO1.
Conclusions:
- Arginine methylation by PRMT1 acts as an inhibitory modification against Akt-mediated FOXO1 phosphorylation.
- PRMT1-mediated methylation stabilizes FOXO1, preventing its degradation and influencing apoptosis.
- This study reveals a novel regulatory mechanism for FOXO transcription factors.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Regulation of Angiogenesis and Blood Supply